Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (371-380 of 418) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studiesZilun Hu, Cailan Wang, Peter W Glunz, et al.
Journal of Medicinal Chemistry|January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitorsMimi L Quan, Pancras C Wong, Cailan Wang, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubilityTammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitorsMichael M Miller, Yalei Liu, Ji Jiang, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPatrick Y S Lam, Charles G Clark, Renhua Li, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Sulfonylated Benzothiazoles as Inhibitors of Endothelial LipaseJames A Johnson, George Tora, Zulan Pi, et al.
Journal of Medicinal Chemistry|May 28, 2025
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule AgonistsShun Su, Michael C Myers, Donna M Bilder, et al.
Pageof 42

Showing results (371-380 of 418) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studiesZilun Hu, Cailan Wang, Peter W Glunz, et al.
Journal of Medicinal Chemistry|January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitorsMimi L Quan, Pancras C Wong, Cailan Wang, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, Pravin S Shirude, Daniel L Cheney, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubilityTammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitorsMichael M Miller, Yalei Liu, Ji Jiang, et al.
Journal of Medicinal Chemistry|October 3, 2003
Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPatrick Y S Lam, Charles G Clark, Renhua Li, et al.
ACS Medicinal Chemistry Letters|January 8, 2019
Sulfonylated Benzothiazoles as Inhibitors of Endothelial LipaseJames A Johnson, George Tora, Zulan Pi, et al.
Journal of Medicinal Chemistry|May 28, 2025
The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule AgonistsShun Su, Michael C Myers, Donna M Bilder, et al.
Pageof 42